DPP4 and type 2 diabetes mellitus: Taken together, these findings suggest that the anti-diabetic effects of 1CBR are mediated through direct DPP-IV inhibition and stimulation of GLP-1 secretion, primarily attributed to the bioactive peptides GPFPLPD and APDSGNFR, making 1CBR a promising natural therapeutic candidate for type 2 diabetes.